findmyKOL
Clinical trialNCT05807711CompletedPhase 4Interventional

Efficacy of L-methylfolate and Methylcobalamine in Treating Resistant Hypertension Associated With Elevated Serum Homocysteine in Hemodialysis Patients.

SponsorAlexandria UniversityEnrollment51End Stage Renal DiseaseHypertension, Renal
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Hanan M El-gowelli, PhD

    Professor of Pharmacology & Toxicology, Alexandria University

    Principal Investigator
  • Hesham A Elghoneimy, PhD

    Associate Professor of Internal Medicine, Alexandria University

    Principal Investigator
  • Mohamed S Salem, PharmD

    Master's student in Clinical Pharmacy and Pharmacy Practice, Alexandria University.

    Principal Investigator
  • Noha A Hamdy, PhD

    Associate Professor of Clinical Pharmacy, Alexandria University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Egypt
  • Faculty of Pharmacy, Alexandria University

    Alexandria, Alexandria Governorate, Egypt

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Apr 2023
Primary completion
1 May 2024
Completion
1 May 2024
Last update posted
13 Jan 2025
Registered enrollment
51
Registry id
NCT05807711

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.